🇺🇸 FDA
Pipeline program

RNAseq

GroupeFDPC

Unknown gene_therapy active

Quick answer

RNAseq for Non-small Cell Lung Cancer is a Unknown program (gene_therapy) at Takeda with 1 ClinicalTrials.gov record(s).

Program details

Company
Takeda
Indication
Non-small Cell Lung Cancer
Phase
Unknown
Modality
gene_therapy
Status
active

Clinical trials